1 week Ago By ABMN Staff
Surgery Partners, Inc. ( NASDAQ:SGRY – Get Free Report ) has been given a consensus recommendation of “Moderate Buy” by the seven analysts that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company.
The average 12 month target price among brokerages that have covered the stock in the last year is $39.86. Several analysts have issued reports on the stock.
Macquarie began coverage on shares of Surgery Partners in a research report on Friday, June 28th. They set an “outperform” rating and a $31.00 price target for the company.
Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research report on Monday, August 19th. Royal Bank of Canada reissued an “outperform” rating and set a $49.
00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. Benchmark reaffirmed a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Monday, August 26th.
Finally, Citigroup dropped their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th.
Read Our Latest Report on Surgery Partners Insider Activity at Surgery Partners Institutional Inflows and Outflows A number of hedge funds and other institutional investors have recently made changes to their positions in SGRY. BNP Paribas Financial Markets grew its stake in Surgery Partners by 54.1% in the fourth quarter.
BNP Paribas Financial Markets now owns 315,083 shares of the company’s stock worth $10,080,000 after purchasing an additional 110,664 shares during the period. First Eagle Investment Management LLC boosted its stake in Surgery Partners by 16.5% during the first quarter.
First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock worth $10,127,000 after acquiring an additional 48,100 shares in the last quarter. Iron Triangle Partners LP purchased a new stake in Surgery Partners in the fourth quarter worth about $33,415,000. Norges Bank bought a new position in shares of Surgery Partners during the fourth quarter valued at approximately $25,765,000.
Finally, Bamco Inc. NY lifted its holdings in shares of Surgery Partners by 100.0% during the first quarter.
Bamco Inc. NY now owns 90,000 shares of the company’s stock valued at $2,685,000 after purchasing an additional 45,000 shares during the last quarter. Surgery Partners Stock Performance NASDAQ:SGRY opened at $30.
18 on Thursday. The company has a market capitalization of $3.84 billion, a price-to-earnings ratio of 43.
58, a PEG ratio of 2.33 and a beta of 2.76.
The business has a 50 day moving average of $28.79 and a 200 day moving average of $27.62.
The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.
69. Surgery Partners has a 1-year low of $22.05 and a 1-year high of $36.
92. Surgery Partners ( NASDAQ:SGRY – Get Free Report ) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.
21 EPS for the quarter, topping the consensus estimate of $0.20 by $0.01.
Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%.
The firm had revenue of $762.10 million for the quarter, compared to the consensus estimate of $735.94 million.
During the same period last year, the firm posted $0.25 earnings per share. The business’s revenue was up 14.
2% compared to the same quarter last year. On average, sell-side analysts predict that Surgery Partners will post 0.87 earnings per share for the current fiscal year.
About Surgery Partners ( Get Free Report Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. Read More Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.
com's FREE daily email newsletter ..
